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CAPILLARY BLOOD GAS MEASUREMENT AS A NOVEL MEANS OF ASSESSING FLAP 
PERFUSION IN FREE TISSUE TRANSFER. 
Aaron K. Remenschneider and Douglas A. Ross (Sponsored by Dr. Clarence Sasaki). Section of 
Otolaryngology, Department of Surgery, Yale University, School of Medicine, New Haven, CT. 
 
 
To demonstrate that in comparison to implantable O2 microelectrodes, Capillary Blood Gas 
measurements represent a reliable, accessible and easy method of identifying failing free flaps, 
and furthermore, to assess post-operative free-flap monitoring techniques nation-wide, 
determining the openness of surgeons to new surveillance modalities.  
 
Groin fasciocutaneous flaps were elevated in 10 rats and following arterial or venous occlusion, 
oxygen microelectrode measurements (pO2 and flow) and Capillary Blood Gas measurements 
(pO2, pCO2, pH, HCO3) were obtained at 0, 10 and 20 minutes. A nine question, Internet based 
survey on post-operative flap surveillance techniques was sent to the personal email addresses of 
238 microvascular surgeons from around the country. Response data were collected and analyzed 
utilizing an online resource. 
 
Measurements with capillary blood gas paralleled measurements with O2 microelectrodes. 
Average capillary blood gas pO2 fell from 42.72 mm Hg at 10 minutes and then to 28.67 mm Hg 
at 20 minutes. Average pH fell from 7.38 to 7.33 at 10 minutes and to 7.30 at 20 minutes. Results 
were statistically significant with both the paired Student’s t test and the Wilcoxon signed rank 
test. 75% of survey respondents indicated that clinical assessment was more important than 
available adjunctive tests in the decision to re-explore the vascular pedicle in a threatened free 
flap and 56% listed pinprick with flap bleeding as an important marker of flap health in their 
practice. 90% of respondents indicated they are open to new quantitative monitoring techniques.  
 
While providing users the ability to simultaneously monitor accepted modalities of flap 
surveillance, pH and pO2, the capillary blood gas is a reliable and reproducible marker of flap 
tissue health. Given that no single monitoring modality enjoys a clear preference among 
microvascular surgeons and that more than half of these surgeons already utilize pinprick 
assessment of the flap, this study demonstrates that the capillary blood gas may be well 
positioned for further study in humans. 
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INTRODUCTION 
Any patient receiving a diagnosis of cancer in the head and neck will be rightfully 
distraught about the implications of their disease and its treatment. Composing ~3% of all 
newly diagnosed cancer each year,(1) head and neck malignancies are most often 
squamous cell carcinomas arising in the oral cavity, pharynx, larynx, nasopharynx or on 
the scalp. Curative treatment for these cancers relies on surgery, radiation or 
chemotherapy or some combination of the three, and while survival data is good relative 
to other cancers, there remains significant room for improvement. In treatment of 
moderate to advanced cancer, one major modality of therapy involves surgical removal of 
the tumor and reconstruction of the head and neck defect with a tissue autograph. Since a 
successful outcome depends on the health of the transplanted tissue and its vascular 
supply, detecting early warning signs of flap failure is of utmost importance. Flaps with 
compromise at their vascular pedicle can be returned to the operating room for repair of 
the artery or vein if found early in the course of arterial ischemia or venous congestion. 
Accordingly, postoperative monitoring of the graft is of central importance. This thesis 
will report on the validation and application of a novel method of free flap autograph 
monitoring. 
 
Epidemiology and Etiology of Head and Neck Cancer 
In the United States in 2008 it is estimated that 35,310 men and women will be diagnosed 
with cancer of the oral cavity/pharynx and 12,250 men and women will be diagnosed 
with laryngeal cancer.(1) Men are diagnosed at a rate three times as frequent as women, 
although year over year trends suggest that this gap is narrowing. For patients carrying a 
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diagnosis of squamous cell carcinoma of the larynx, oral cavity and pharynx, 11,350 will 
die from their disease in 2008.(1) Mortality data is nearly identical among black and 
white women, but mean survival time has been found to be markedly shorter in black 
men when compared to white men.(2) Fortunately, annual incidence trends in head and 
neck cancer are on the decline with decade length period changes between -1% and -
2.7% from the 1970s to 2005.(1)  
Head and neck cancers occur along the aero-digestive tract and squamous cell 
carcinoma is highly correlated with the abuse of alcohol and tobacco.(3) In recent years, 
public health efforts to curb tobacco use appear to have led to a decline in the overall 
rates of laryngeal, oral cavity and pharyngeal cancers(1); however, given the 
demographics of our aging population and their history of exposure to these carcinogens, 
the health care burden of these patients is likely not to change in the next two decades. 
Human papilloma virus (HPV) has is also associated with head and neck cancer, with 
95% of cervical squamous cell carcinomas linked to persistent HPV infection.(4) While 
our understanding of this relationship is not completely clear, it appears that HPV 
infection may play a role as a carcinogen in a subset of head and neck cancer patients. 
 
Presentation of Head and Neck Cancer 
Cancers of the head and neck may go unnoticed or unappreciated at early stages because 
patients can present with a constellation of symptoms seemingly unrelated to serious 
disease. A detailed history and examination can properly identify the primary tumor in 
95-97% of cases.(5) Patient complaints can be stereotyped by location as indicated below 
-  
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• Oral Cavity – Patients may complain of non-healing ulcers or persistent masses of the 
tongue, lip, buccal mucosa, floor of mouth, hard palate, alveolar ridge or retromolar 
trigone. Because of the rich lymphatic drainage to the oral cavity, these patients may 
also present with a mobile neck mass, usually ipsilateral to the lesion.  
• Oropharynx and Supraglottic Larynx - Because these lesions arise in areas with little 
direct sensory innervation, presenting symptoms of cancers here include general 
dysphagia or odynophagia. Patients may also complain of otalgia due to referred pain 
via Arnold’s or Jacobson’s branch of the glossopharyngeal or vagus nerves, 
respectively.  Cervical adenopathy is also an extremely common presenting sign in 
these patients as this area is drained bilaterally by a rich plexus of lymphatics.  
• Larynx – Classically, patients will present with hoarseness or a change in voice 
quality. Patients with more advanced disease may have stridor, hemoptysis or chronic 
cough.  
• Nasopharynx and Paranasal Sinus – Unilateral serous otitis media in an adult raises 
concern for Eustachian tube blockade, possibly by a tumor, but these patients may 
also present with a neck mass as their first sign of disease. Patients with paranasal 
carcinoma often complain of nasal obstruction or epistaxis.  
 
Cost of Head and Neck Cancer 
According to recent findings in a Surveillance Epidemiology and End Result (SEER)-
Medicare retrospective analysis, patients with squamous cell carcinoma of the head and 
neck accrue large medical bills – 25,500 dollars per year more than the costs of a 
matched control without head and neck cancer.(6) These costs are reflective of the 
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complexity of their care, which involves head and neck surgeons, radiation oncologists 
and medical oncologists as well as inpatient and outpatient ancillary staff. Given that the 
cost of treatment increases with increasing stage of disease, (primarily due to a difference 
in relapse rates),(7) there are not only benefits in disease outcome, but also financial 
incentives in diagnosing and treating head and neck cancer at an earlier stage. Several 
large-scale primary care screening programs for head and neck cancer have been studied 
in Britain through the National Institute for Health and Clinical Excellence (NICE) and 
they have suggested a greater need for high-risk opportunistic screening by general dental 
and medical practitioners.(8) However, it has been found that there is no cost-effective 
role for imaging in the screening of primary lesions in the head and neck, even in high-
risk populations.(9)  
 
Treatment in Head and Neck Cancer 
Treatment for head and neck cancer patients is often long, complex and costly.(6, 10, 11) 
Workup and treatment planning are frequently undertaken by a multidisciplinary tumor 
board that includes surgical, radiation and medical oncologists. Head and neck cancer is 
based on the AJCC’s TNM staging scale and is correlated with tumor size, location of 
origin and involvement of surrounding structures. (Appendix 1)(12)  
Patients presenting with early/localized staged disease and treated with either 
surgery or radiation alone enjoy five year survival rates of 62.5 percent to 99 percent, 
depending on tumor site and biological factors.(1, 13) However, more than fifty percent 
of all head and neck cancer patients present with locally advanced disease (stage III or 
IV) and necessitate more aggressive treatment.(1) Several randomized trials report that 
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these patients, whether receiving primary surgery followed by radiotherapy or induction 
chemotherapy followed by radiation, have five-year survival rates of 40 percent to 50 
percent.(14, 15) Because outcome data for primary radiation versus primary surgery have 
paralleled each other for the past two decades, large regional variations in treatment 
protocols exist in the United States.(10, 16) At this institution, locally advanced disease 
may be treated primarily with aggressive surgical intervention, and when necessary, free 
flap repair. Surgical treatment is also utilized as salvage therapy in patients who fail 
primary radiation. 
 
Reconstruction in Head and Neck Cancer 
Reconstructing surgical defects following head and neck oncological resections is a great 
challenge. This difficulty stems largely from the lack of locally available tissues and/or 
the presence of surrounding irradiated tissues. Any irradiated tissues used in 
reconstruction have a higher failure and fistula rate than normal.(17, 18) Thus, in order to 
maximize the oncological benefits of surgery, reconstruction needs to be achieved 
quickly so that patients may go on to receive adjuvant therapies as soon as possible.  For 
these reasons, free tissue transfer remains the best reconstructive option for many patients 
with head and neck cancer. 
The use of free tissue flaps in head and neck reconstruction has expanded the 
opportunities for surgical resection and they are indispensable treatment options today for 
patients with advanced disease. Free tissue flaps have been described from over 20 donor 
sites and may include everything from skin and subcutaneous fat to muscle and bone.(19) 
The most frequently utilized flaps are the radial forearm fasciocutaneous flap, the rectus 
 10 
muscular flap, the anteriolateral thigh muscle flap, the fibular bone and cutaneous flap 
and the scapular bone and muscular flap. Each of these volumes of tissue is harvested in a 
way to preserve its implicit vasculature and to minimize damage to tissues surrounding 
the donor site. Each flap is inset at the site of the oncologic resection and its vasculature 
anastomosed via microsurgery to a local artery and vein. The donor site is then covered 
with a local closure or by a split thickness skin graft taken most often from the thigh.  
 
Flap Monitoring in Head and Neck Cancer 
Despite technological advances in surgery, free tissue transfer maintains a failure rate of 
approximately 2 percent to 5 percent. (20, 21) Most commonly, free tissue transfer 
failures result from impaired arterial or venous flow, localized to the anastomosis. 
Ischemic times of greater than 6 hours results in irreversible tissue damage due to a “no-
reflow” phenomenon. (22-24) In a no-reflow condition, the ischemic damage of worry is 
not the tissue parenchyma but the vascular network which itself collapses, thus 
preventing the proper return of blood from the ischemic tissue. For free flaps, the 
vascular compromise must be discovered within this narrow time frame. If this is the 
case, flap salvage is an option with success rates ranging from 69 percent to 95 percent. 
(20, 25, 26) 
Clinical assessment as defined in the literature in free flap monitoring relates to 
the observation of color, capillary refill, skin turgor, tissue edema.(27) Because clinical 
assessment remains the gold standard in postoperative flap monitoring, numerous devices 
recording the metabolic microenvironment (also known as ‘objective’ or ‘adjunctive’ 
monitoring techniques) have been proposed to aid in identifying previously undetected 
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failed flaps. These include implantable Doppler flow systems, laser Doppler flow 
monitors, implantable oxygen tension monitors, implantable pH probes, and even 
implantable microdialysis catheters.(28-35) Because tissue oxygen tension is accepted as 
a sensitive and reliable method of determining adequacy of perfusion, researchers, since 
the 1980’s, have helped to develop implantable microelectrodes that may be introduced 
into tissue to provide an instantaneous and constant measure of the oxygen 
availability.(31, 36-40) Impairing arterial or venous perfusion in experimental models has 
demonstrated a decline in the pO2 and flow as measured with these devices.(31, 37) In 
humans, implantable microelectrodes have been used to appropriately identify and 
salvage free flaps with impaired perfusion,(32) but due to high cost and detailed operator 
training, these instruments have not been widely adopted.(31) 
Oxygenation in tissues is directly related to oxygen levels in arterial blood.  In 
humans, the gold standard for determining oxygenation and acid/base status remains the 
arterial blood gas (ABG).  Repeated arterial puncture, however can lead to complications 
including pain, arterial injury, thrombosis with resultant distal limb ischemia and 
hemorrhage.(41, 42) Capillary blood gas (CBG) sampling is an alternate easy and 
inexpensive means of measuring acid/base status with diminished risk. CBG has been 
extensively studied in the pediatric/neonatal population as a less invasive determinant of 
respiratory status where ABG risks are greater. Researchers have found a significant 
correlation in pH, pCO2 and pO2 among ABG, venous blood gas (VBG) and CBG 
measurements, and as a result a host of studies in the pediatric literature confirm the 
validity of CBG in determining pH and pCO2 status of critically ill children.(43, 44)  
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This thesis seeks to validate the capillary blood gas as a predictive monitor of the 
metabolic microenvironment of the postoperative free flap and to determine whether 
microvascular surgeons nationwide would be able and willing to supplement their current 
protocols with a more objective monitoring technique. 
 
STATEMENT OF PURPOSE AND SPECIFIC AIMS OF THE THESIS 
By transferring the application of capillary blood gas from a generalized determinant of 
oxygenation and acid/base status to a focused measurement of the metabolic micro-
environment, our objective in this study was to show that the capillary blood gas may 
represent an easy to use and reliable new method of identifying failing flaps secondary to 
venous occlusion, thus supporting its use as a complement to clinical assessment. 
 
Without a widely agreed upon standard protocol for postoperative flap monitoring and 
without national data on monitoring trends in the last ten years, the purpose of this survey 
was to learn how microvascular surgeons were managing patients postoperatively, assess 
the number of individuals still utilizing clinical assessment as their primary gauge of flap 
health and discover the openness of these individuals to new monitoring techniques.  
 
MATERIALS AND METHODS: 
1. Capillary Blood Gas Assessment of Free Flap Perfusion 
This portion of the thesis was completed by Aaron Remenschneider and Greg 
Lesnik (Otolaryngology resident) with technical assistance from Dr. Peter Herman, 
neurophysiology.  
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After receiving Institutional Animal Care and Use Committee (IACUC) approval, 10 
male Sprague Dawley rats weighing roughly 300 g were purchased.  All animals were 
housed in accordance with the Yale Animal Committee standards in the preoperative time 
period.  During the experiment, animals were anesthetized with an intraperitoneal 
injection of ketamine 90mg/kg and xylazine 5mg/kg body weight.  Level of anesthesia 
and respiratory status were continually monitored.  Repeat injections of ketamine 
45mg/kg and xylazine 2.5mg/kg body weight were given for animal arousal prior to 
completion of the study.  Animals were then placed on a heating mat warmed to 37.5 
degrees Celsius.  Core body temperature was continually measured via a rectal 
thermometer.  Clean techniques were employed as sterility was not essential.  Rats were 
euthanized at the completion of each experiment via lethal injection of pentobarbital at 
150mg/kg per IACUC protocol.   
 
Surgical Procedure 
Bilateral abdomen and groin sites were shaved.  A groin fasciocutaneous flap was then 
elevated and completely detached from surrounding tissues ranging vertically from the 
costal cartilage to mid-thigh and horizontally from just lateral to midline to the axillary 
line.  The epigastric artery and vein were then carefully identified and followed to their 
insertion on the femoral vessels.  Using an operating microscope, the sheath of the 
epigastric vessels was entered, epigastric nerve divided and artery and vein separated.  
The femoral sheath was similarly isolated.  All flaps revealed a visible arterial pulse 
along the length of the epigastric artery post-operatively.  The flap was then fastened to 
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the abdomen of the rat to prevent movement and ensure warming.  Following completion 
of experimentation on one side a contralateral groin fasciocutaneous flap was then 
elevated in the same manner.  
Venous clamping was performed by placing a microclamp around the epigastric 
vein just proximal to its insertion on the femoral vein under direct microscopic 
visualization.  Care was made not to contact or stretch the artery.  Proper placement was 
confirmed by visual lack of blood distal to the clamp and visualization of a persistent 
pulse in the epigastric artery.  Arterial clamping was performed by similarly placing a 
microclamp around the epigastric artery.   Successful clamp placement was confirmed by 
lack of pulsation distal to the clamp.      
 
Oxygen Microelectrode Measurements 
Bare Fibre pO2/Temperature Sensor type microelectrodes with a tip diameter of 4um 
were used (Oxford Optronix OxyLab, Oxford, UK).  Microelectrodes were attached to 
the OxyLite/OxyFlo combined channel monitor for interpretation (Oxford Optronix 
OxyLab, Oxford, UK).  Continuous measurements of pO2, flow and temperature were 
measured and recorded on a desktop computer using Spike2 software (Cambridge 
Electronic Design, Cambridge, UK).  Tissue oxygen levels are determined by the 
flourescence quenching principal where bursts of LED light transmitted via fiberoptics 
excite a platinum based dye in the electrode tip, resulting in emission of fluorescent light 
which is absorbed by local oxygen molecules.  The difference between absorbed and 
measured reflected light represents local oxygen tension.  Tissue flow is determined via 
Laser Doppler Flowmetry [LDF] where light from the probe tip is projected into the 
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tissue, scattered and then reabsorbed by a sensor.  Properties of reflected light from 
erythrocytes and stationary tissues differ, representing the Doppler shift, and can be 
interpreted as local flow over time by the OxyFlo monitor. The numeric calculation of 
LDF is based on the concentration of local red blood cells and the velocity at which they 
travel. Local temperature is determined by an attached thermocouple transducer.       
 
Capillary Blood Gas Measurements 
CBG measurements were obtained using heparanized capillary tubes and an ABL5 
Capillary Blood Gas Monitor (Radiometer Copenhagen, Copenhagen Denmark).   
 
Capillary Blood Gas Assessment of Free Flap Perfusion: Experimental Protocol 
A. Tissue Oxygen Tension: 
Using stereotactic manipulators, the oxygen microelectrode was inserted into the 
fascia to a depth of approximately 1mm.  Electrodes were consistently inserted 5mm 
lateral to the split in the epigastric pedicle.  Continuous readings of pO2, flow and 
temperature were confirmed and recorded.  Flaps were allowed to equilibrate for 
approximately 20 minutes or until steady state values were obtained for all 3 parameters.  
Venous (n=4 ) or arterial  (n=3 ) clamping was then performed as previously mentioned.  
Measurements were continually recorded for 20 minutes.  Due to technical difficulties 
successful readings were obtained from 5 flaps following occlusion: venous (n=3), 
arterial (n=2). 
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B. Capillary Blood Gas Measurements: 
Flaps were allowed to equilibrate for 20 minutes following surgery.  CBG 
measurements were then obtained via the following manner.  Under direct microscopic 
visualization, the epigastric vein adventitia was grasped using Jewlers forceps.  A 30 
gauge needle with attached heparinized 1cc syringe was then carefully used to cannulate 
the epigastric vein.  Approximately 100 microliters of blood were then aspirated directly 
from the vein.  Blood samples were then transferred into a heparinized capillary tube and 
inserted into the ABL5 blood gas machine for measurement of pH, pO2 and pCO2.  
Further blood loss from the puncture site was prevented by applying gentle pressure 
using a cotton tipped applicator.   
In the experimental arm, following venous occlusion, repeat CBG measurements 
were obtained at 10 and 20 minutes.  CBG measurements were obtained in a similar 
manner by again cannulating the epigastric vein with a 30 gauge needle distal to the 
microclamp.  Approximately 100 microliters of blood were gently aspirated directly from 
the vein within a 1 minute time period.  Adequate perfusion was confirmed prior to 
obtaining blood samples by the visible presence of a pulse in the epigastric artery leading 
to the flap.  CBG readings obtained with less than 100 microliters of blood produced 
erroneous results and were therefore immediately repeated by reaspirating a sufficient 
sample from the epigastric vein.  Due to technical constraints largely stemming from the 
small caliber of the epigastric vein and inherent trauma from repeated cannualization 
several data points were missed.    
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Capillary Blood Gas Assessment of Free Flap Perfusion: Analysis of Data 
CBG measurements were recorded and the values of pO2, pH and pCO2 as well as HCO3 
(calculated: Henderson Hasselbalch equation) at 0, 10 and 20 minutes following venous 
clamping in all eight flaps. Data on average CBG measurements or standard deviations 
for pH and pO2 are not available for an a priori power analysis; thus, using sample sizes 
reported in the literature for similar research(31, 33, 34, 37) and a post hoc power 
analysis, we reached power over 95 percent in both pH and pO2 samples. Changes from 
pre-clamp controls were statistically evaluated using a two-tailed paired Students t test 
and the Wilcoxon signed rank test.  Statistical significance was defined as a P value 
<0.05.  Data were analyzed using SPSS software and with the support of Yale University 
Statistics Laboratory.  
 
2. Yale National Survey of Free Flap Monitoring Technique 
This portion of the thesis was completed by Aaron Remenschneider, under mentorship 
from Dr. Douglas A. Ross, Section of Otolaryngology.  
 
Development of the Survey 
After consulting the small body of literature on institutional and surgeon use of various 
flap monitoring techniques, a library of common questions used in these surveys was 
constructed. ‘Clinical Assessment’ techniques, also known as subjective monitoring 
techniques were differentiated from ‘Objective’ monitoring techniques that rely on a 
specified and measured parameter of the tissue. Monitoring devices and techniques 
included were those found in the literature as well as recently reported innovations from 
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2002-2007. Surgeons were asked whether they preferred “clinical assessment’ to 
‘objective’ monitoring. They were also asked whether they would be open to new 
monitoring devices, if they worked at resident staffed hospitals and who was responsible 
for post-operative care of patients with free flaps. Additionally, the survey asked about 
the volume of reconstructive cases, whether costs were a consideration in monitoring 
technique and whether staff training was a barrier to new surveillance practices. All 
questions were multiple choice and allowed respondents to select more than one response 
where appropriate. Each question also allowed for both write in responses and 
commentary on the question.  
 
Distribution of the Survey 
The survey was built with the help of the Professional edition of the online survey 
creation tool, SurveyMonkey (SurveyMonkey.com Corporation, Portland, OR). Contact 
information for reconstructive surgeons from the 200 largest head and neck 
reconstructive centers was obtained from Chris Ubinger of Metronic Corporation. 238 
email addresses were obtained and entered into the online survey database. An initial 
email with a short introduction of the study’s purpose introduced the online survey 
followed by a web-link to direct participants to the SurveyMonkey website. The online 
survey was open for response for 30 days. One follow up email was sent to non-
respondents at the two-week mark. Only one response per surgeon was accepted. Overall 
response rate was 42% (99/238). 
 
 
 19 
Collection of Survey Data 
All survey data was collected with the support of SurveyMonkey Professional edition 
(SurveyMonkey.com, Portland, OR), which allows for the creation of charts, graphs and 
analysis by response type.  
 
RESULTS: 
1. Capillary Blood Gas Assessment of Free Flap Perfusion 
Oxygen Microelectrode, Venous Clamping 
Mean oxygen tension prior to venous clamping was 28.53 mmHg with a mean 
flow of 317 (Table 1).  A clear steady state without fluctuations in pO2 or flow were 
observed in all experiments at 20 minutes post-procedure.  Venous clamping resulted in a 
gradual decline in pO2 across all time points.  At 5, 10 and 15 minutes mean pO2 was 
23.73 mm Hg, 17.50 mm Hg and 16.26 mm Hg, respectively.  Similarly venous clamping 
resulted in decreased flow across all time points.  At 5, 10 and 15 minutes mean flow was 
288, 280 and 249 respectively. Average decline in pO2 from control at 15 minutes was 
12.27 mm Hg. Figure 1 demonstrates the steady state pO2 at 20 minutes and the gradual 
decline in both pO2 and flow following venous clamping.   
 
Arterial Clamping 
Mean oxygen tension prior to arterial clamping was 18.85 mm Hg with a mean flow of 
497.5 (Table 1).  Arterial clamping resulted in a rapid decline in pO2 from steady state 
values.  Similarly, the 5 minutes mean flow decreased from 497 to 153.  Figure 2 
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demonstrates the steady-state pO2 at 20 minutes and the rapid decline in pO2 and flow 
following arterial clamping in one experiment.   
 
Capillary Blood Gas Measurements: 
Serial CBG measurements at control and over time following venous clamping may be 
found in Table 2.  Mean pO2 prior to venous clamping was 42.71 (+/- 5.12) mm Hg.  
Following venous clamping, mean pO2 measurements at 10 and 20 minutes declined to 
31.57 (+/- 7.83) mm Hg and 28.67 (+/- 6.28) mm Hg, respectively (Figure 3).  Subjecting 
the data to a two tailed, paired Student’s t test, this negative change in pO2 over the 
course of the first 10 minutes was statistically significant at the P < 0.05 level (t(5) = 
3.733, *P = 0.014, 95% CI = (3.74, 20.26)) (Table 3), and the decline continued over the 
following 20 minutes (t(4) = 13.870, *P < 0.001, 95% CI = (14.72, 22.08)). The 
Wilcoxon signed rank test demonstrated CBG successfully detected falling pO2 in seven 
of seven flaps at 10 minutes postclamp (P < 0.001). This was also true at 20 minutes 
when six of six pO2 values had dropped (P < 0.001).  
Mean pH prior to venous clamping was 7.38 (+/- 0.04).  Following venous 
clamping pH measurements at 10 and 20 minutes decreased to 7.33 (+/- 0.05) and 7.30 
(+/- 0.04), respectively (Figure 2).  The negative change in pH during the first 10-minute 
period was statistically significant at the P < 0.05 level using the Student’s t test (t(6) = 
2.997, *P = 0.024, 95% CI = (0.01, 0.16)) (Figure 4). The Wilcoxon test showed CBG 
detected falling pH in six of seven flaps at 10 minutes (P = 0.031), and in five of six flaps 
at 20 minutes (P = 0.062).  
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Mean CO2 and HCO3 prior to venous clamping were 41.13 (+/- 7.68) mm Hg and 
23.38 (+/- 3.11) respectively.  Following venous clamping pCO2 decreased at 10 minutes 
to 39.00 (+/- 9.80) mm Hg and had increased at 20 minutes to 43.50 (+/- 6.28) mm Hg.   
HCO3 decreased from control at 10 and 20 minutes to 21.16 (+/- 3.66) and 21.17 (+/- 
6.11).  Neither parameter showed significant changes over time (Table 3). The Wilcoxon 
test did not find significance for the changes in either CO2 or HCO3.  
 
2. Yale National Survey of Free Flap Monitoring Technique 
Respondents 
An electronic invitation to participate in the Yale Free Flap Monitoring Survey 
was sent to 238 individuals at academic and private practice medical centers nationwide. 
Of the 238 distributed, 99 surveys were completed online for a response rate of 42 
percent. All 99 of those who started the survey completed it. 82 of the 99 or 84.5 percent 
indicated that they worked in academic institutions staffed with residents (Figure 5). 65.7 
percent of respondents stated that nurses provide the majority of free flap monitoring 
post-operatively, while 23.2 percent stated it was resident house-staff that did the 
majority of monitoring (Figure 6). Attending surgeons and microvascular fellows were 
found to be less frequently involved in flap monitoring. Nurses were found to provide the 
majority of postoperative flap care and surveillance regardless of whether the surgeon 
worked at an academic center or in a private group. 33 percent of respondents perform 
more than 50 free flap reconstructions per year while 45.5 percent perform less than 30 
per year (Figure 7). Respondents not working in academic medical centers tended to 
perform fewer free flaps per year than those in academic centers (Figure 8).  
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Monitoring Technique 
All respondents indicated that they utilize clinical assessment in postoperative flap 
surveillance. At 98 and 97 percent, nearly all surgeons use capillary refill and flap color 
as markers of flap health, respectively (Figure 9). Three respondents commented that 
subjective temperature (taken with the back of a knuckle) was also an important clinical 
assessment technique used in their practice. 98 percent of respondents also use adjunctive 
measures to monitor flap health. 55.7 percent employ pin-prick tests, 44.3 percent use 
laser Doppler and 21.2 percent use the hand held Doppler ultrasound (Figure 10). Other 
adjunctive monitoring techniques were used with lower frequency. When asked to 
prioritize clinical assessment or adjunctive testing, 74.7 percent preferred clinical 
assessment as described in question 1 of the survey (Figure 11). 15 percent indicated that 
they rely heavily on both. 
When separated by institutional affiliation, 60 percent of academic microvascular 
surgeons indicated they use pin-prick assessment while only 26.7 percent of private 
reconstructive surgeons do (Figure 12). There is also a wider distribution of techniques 
among private surgeons and higher percent (30%) use temperature monitoring whereas 
only 10 percent of academic surgeons use this. Private microsurgeons are also twice as 
likely to rely on adjunctive monitoring tests in the decision to take a flap back for 
revision when compared to academic microvascular surgeons. 
 
Monitoring Staff and Openness to New Technique 
89.9 percent of respondents suggested that they would be open to different monitoring 
techniques (Figure 13), and 67.7 percent indicated that staff training would not be a 
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barrier to the implementation of new monitoring technologies (Figure 14). If a new 
monitoring device was to be considered, 67.7 percent of respondents stated that the 
expense of the device would be a factor into their willingness to adopt the piece of 
equipment (Figure 15). These did not differ significantly between academic and private 
microvascular surgeons.  
 
DISCUSSION:  
For many patients undergoing head and neck oncologic resection free tissue transfer 
remains the best reconstructive option.  Despite technological advances, flap failure rates 
due to arterial and venous thrombosis still approximate 5%.(20, 21) Studies have clearly 
shown tissue failure from ischemia occurs in two parts: acutely due to the initial hypoxia 
with ensuing acidosis and later due to reperfusion injury more commonly referred to as 
no-reflow phenomenon.(22-24) Research has demonstrated that the no-reflow 
phenomenon may occur in as little as 6 hours.(22) If flap perfusion is found to be 
impaired prior to this critical time, flap salvage is an option with reported success rates 
ranging from 69- 95%.(20, 25, 26) Because of the narrow window of time available to 
correct impaired perfusion, flap surveillance in the post-operative time period is 
paramount. 
 
Adjunctive Monitoring Techniques 
Numerous postoperative flap-monitoring techniques have been developed and trialed 
over the years; however, most harbor limitations, thus curbing their utility in practice.  
The last surveys conducted of reconstructive centers over 10 years ago clearly 
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demonstrated that no one technique is commonly employed and that clinical assessment 
remains the gold standard for monitoring flaps post-operatively.(23, 27, 45) Adjunctive 
surveillance strategies currently used target 1 of 3 physiologic aspects of the flap: flow, 
temperature or oxygen tension. Tissue flow may be monitored primarily in the pedicle 
using hand held Doppler ultrasound probes or implantable Doppler flow systems (28) or 
flow may be monitored in smaller vessels within the tissue using laser Doppler 
flowmetry.(25, 29) Results and opinions on the effectiveness of these techniques however 
have varied.  
Directly measuring oxygen tension within tissues is another accepted technique 
for monitoring flap perfusion. In this experiment flap failure due to arterial or venous 
occlusion was observed in the relatively short time frame of 10 and 15 minutes. 
Furthermore, the differences in the measurement of flow by oxygen microelectrode 
recorded two clearly distinct patterns between arterial and venous compromise (Figures 1 
and 2).  These results are consistent with experiments done in humans that successfully 
identified impaired perfusion, (31, 32) and our experience with the probes validated the 
difficulty of operating and interpreting data from the microelectrode. While 
distinguishing between arterial and venous compromise is helpful, most studies suggest 
clinical assessment can quickly identify arterial compromise as distinct from venous 
congestion.(20, 23, 27, 45) Unfortunately, the major limitations of the microelectrode 
technique remain the costs and the fragility of the oxygen probes. 
One early monitoring technique attempted to directly analyze the acid base status 
of the flap by following pH with an implantable probe.(33, 34) With more advanced 
technology today, we are now able to directly monitor the physiologic milieu of the 
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transferred tissue, observing for changes in biochemical markers as evidence of 
ischemia.(35) While the effectiveness of such experimental techniques has been validated 
in highly controlled and small studies, the costs, both economic and practical remain 
high. 
Reported estimates of proposed monitoring devices include the laser Doppler 
flowmeter ($10,500 + 1200/year),(25) the Microdialysis catheter and analyzer ($26,000 + 
350/patient),(35) or the oxygen microelectrodes ($300-$400/use/patient).(31) We can 
contrast that with the cost of the capillary blood gas, which is dependent only on the 
equipment necessary to obtain the sample and analyze the result: a 20 gauge needle (~3 
cents), a heparinized capillary tube (~5 cents), and the capillary gas machine (nearly 
ubiquitous in hospitals today).  
 
Capillary Blood Gas in the Assessment of Flap Perfusion 
In this experiment, postocclusive changes in oxygen tension and pH were detected with 
capillary blood gas analysis. Raskin and colleagues suggest that continuous monitoring of 
pH after selective occlusion of the epigastric vessels will result in predictable falls in pH 
measurements over time with the ensuing acidosis.(33, 34) The results from our 
experiments paralleled these falls in pH and suggest that CBG is a sensitive indicator of 
acidosis and cellular hypoxia. The observed changes in pH are likely due to increasing 
lactate levels as cells shunt the products of glycolysis towards anaerobic respiration with 
decreasing available O2.(46) Changes in measured pO2 values via CBG following venous 
occlusion in our experiment were statistically significant and directly mimicked the 
changes observed using the oxygen microelectrode system (Tables 1 and 2). The pCO2 
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and calculated HCO3 levels did not show statistically significant changes over time in this 
model (Table 3). While cellular physiology would predict rising pCO2 in congested flaps, 
local HCO3 from arterial blood may have buffered this rise, blunting our observed pCO2 
trends over 20 minutes.  Larger and consistent changes in pCO2 may be observed in flaps 
followed for longer periods. 
 
Limitations 
Rat groin flaps with epigastric pedicles have long been used to simulate fasciocutaneous 
pedicle and free flaps.(47, 48) The elevation of the entire flap, leaving only the vascular 
pedicle allows simulation of arterial clotting or venous thrombosis, with concurrent 
preservation of inflow or outflow from the flap.  This manipulation creates a flap 
microenvironment similar to failing fasciocutaneous free flaps in humans.  Because of the 
urgency required to salvage a failing flap, oxygen tension has often been suggested as an 
ideally sensitive measure of flap health. Several studies have shown oxygen tension to be 
a reliable indicator of flap perfusion.(37, 49-51) However, measured values of the partial 
pressure of oxygen in the tissue varies based on sampling site, distance from vessel 
insertion, warmth, and degree of rubbing.(46, 52, 53) Keeping these principles in mind, 
our study design attempted to ensure uniform warmth, uniform oxygen electrode 
placement and minimal irritation to both the flap and vascular pedicle. 
While our original goal had been to measure flow and oxygen tension with the 
microelectrode and simultaneously sample serial capillary blood gases from the groin 
flap skin, we were limited by both the fragility of the microelectrode and the inadequate 
volume of blood available from local tissues upon laceration. By separating our 
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procedure into two steps, our pO2 and Doppler flow readings from the microelectrode 
demonstrated a healthy pedicle flap with successful arterial and venous clamping 
technique (Figures 1 and 2). Furthermore, it indicated the appropriate postoperative flap 
recovery time was 20 minutes. This ensured a stable, baseline flap perfusion in the CBG 
model, and confirmed that reliable control values could be taken with confidence prior to 
vessel perturbation.  
Because of the limitations of flap size, skin thickness and inadequate local flow 
parameters, adequate capillary blood gas samples could only be obtained via epigastric 
vein cannulation.  This was primarily a result of the small size (3cm x 3cm) and 
constrained blood flow volume to the rat flap. While this technique does not directly 
simulate tissue sampling, it does provide valuable information on the microenvironment 
of the flap. Experimentation in an animal model with a larger flap size (ie: pig) or direct 
sampling from pin-prick assessment in humans would clearly allow adequate blood for 
the capillary blood gas. While extrapolation of our data would suggest that measured 
changes in pH and pO2 from venous samples should also be observed from samples taken 
directly from the tissue, this can not be proven in this study. Importantly, it was our 
observation that it was not the absolute values of pH and pO2 that were predictive, but 
instead the changes between values taken over time. 
 The response rate of our survey was somewhat limited at 44%, with 85% of 
respondents working at resident staffed hospitals. Given that our database of contacts was 
cited to be a roughly 70% academic and 30% private, there was a greater likelihood of 
response among academic surgeons. Unfortunately our survey was conducted 
unknowingly on the heels of another national survey of the same kind and it is possible 
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that some recipients suffered from survey fatigue. Furthermore, the contacts were 
obtained from Chris Ubinger, a representative from the industry side of medicine, who 
compiled the list from the 200 most active reconstructive centers. Since we did not 
capture from the entire universe of reconstructive surgeons, we may have missed 
important constituents who do not practice in ways paralleling our respondents. 
While most head and neck oncologic resections and reconstructions are carried 
out in an academic center, the underreporting from non-academic surgeons may have 
skewed the survey results. This bias may be evident in the perceived surgeon openness to 
new techniques and availability of support staff for flap monitoring.  
 
Application of Capillary Blood Gas in Practice  
It is commonly stated that the ideal free-flap surveillance technique will be reliable, user 
friendly, inexpensive and consistent.(19) As of yet, no technique satisfies all these 
criteria. It was our objective to evaluate the capillary blood gas in this capacity, because 
CBG currently fulfills these criteria in the pediatric/neonatal care setting by virtue of 
being minimally invasive, inexpensive, and reliable. The measurements of pH, pCO2, and 
pO2 are easily obtained and have proven highly correlated among ABG, VBG and 
CBG.(43, 44) A simple prick of the flesh provides several drops of blood that can be 
drawn into a capillary tube and analyzed with either a hand-held or lab-based blood gas 
machine, usually located near neonatal or cardiac units in-house. Pricks can be performed 
as needed or on a standardized schedule to chart oxygen and acid/base status over time. 
With 55 percent of survey respondents noting that they use pinprick and bleeding 
rate already as an adjunctive flap monitoring technique, the act of collecting the blood in 
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a capillary tube for blood gas analysis comes at little cost to the patient or health 
provider. In 1995, Urken described clinical assessment by an experienced microvascular 
surgeon as the most effective means of surveillance.(27) Unfortunately, given the 
nation’s volume of head and neck cancer, not all patients are able to receive care at large 
cancer hospitals, and this was demonstrated in the survey - 45% of free flaps are 
performed at low volume centers (performing < 30 flaps/year). While success rates for 
free tissue transfer are widely reported above 95%(19, 54) this success has been 
repeatedly shown to be correlated with the experience of the surgeon.(20, 26) If clinical 
assessment is to continue as the gold standard for flap monitoring, then individuals at low 
volume centers will be at a distinct disadvantage. Thus the question is whether the 
capillary blood gas can help detect flap failure when clinical observation cannot, and 
certainly this is most relevant for microvascular surgeons performing few flap procedures 
each year. 
This survey demonstrated that private surgeons perform fewer free flap operations 
than do academic surgeons (Figure 8), and it also showed that private surgeons have 
different preferences for flap surveillance (Figure 12). It stands to reason that private 
surgeons at low volume centers are likely the best candidates for the adoption of the 
capillary blood gas. Furthermore, the simplicity, low cost and reliability of the capillary 
blood gas coincide with the preferences indicated by both private and academic 
microvascular surgeons in this survey (Figures 13, 14, 15).  
Despite technological advances, free tissue transfer still maintains a failure rate 
unacceptable to reconstructive surgeons. Post-operative flap surveillance strategies 
provide the best opportunity for identifying and salvaging flaps with impaired perfusion. 
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To date, there remains no universally accepted post-operative monitoring technique to 
complement clinical assessment of the transferred tissue. The field of reconstructive 
surgery needs a uniform method of collecting objective and reliable data, one user-
friendly enough to be employed with minimal training by ancillary health care staff. In 
this study, capillary blood gas proved to be a powerful tool for evaluating impaired 
perfusion to a flap because it provides users the ability to simultaneously monitor two 
accepted methods of flap surveillance: pO2 and pH, while doing so in an inexpensive and 
reliable manner. The finding that the simple CBG is a useful monitoring tool carries 
significant weight and should merit further evaluation in humans. 
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APPENDICES  
Appendix 1. 
Oral Cavity and Oropharynx 
Tis Carcinoma is in situ 
T1 Tumor is 2 cm or less in greatest dimension 
T2 Tumor is more than 2 cm but not greater than 4 cm in greatest dimension 
T3 Tumor is more than 4 cm in greatest dimension 
T4a Tumor invades adjacent structures: cortical bone, muscle of tongue, larynx, medial 
pterygoid, hard palate or mandible 
T4b Tumor invades masticator space, pterygoid plates, or skull base and/or encases the 
internal carotid artery 
 
Supraglottis 
T1 Tumor is limited to one subsite of the supraglottis, with normal vocal cord mobility 
T2 Tumor invades mucosa of more than one adjacent subsite of the supraglottis or glottis, 
without fixation of the larynx 
T3 Tumor is limited to the larynx with vocal cord fixation and/or invades the postcricoid 
area, pre-epiglottic tissues, paraglottic space and/or thyroid cartilage erosion 
T4a Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx 
(trachea, soft tissues of neck, strap muscles, thyroid, esophagus) 
T4b Tumor invades prevertebral space, encases the carotid or invades the mediastinum 
 
Glottis 
T1 Tumor is limited to the vocal cords with normal mobility 
T2 Tumor extends to the supraglottis and/or subglottis and/or with impaired vocal cord 
mobility 
T3 Tumor is limited to the larynx with vocal cord fixation and/or invades paraglottic 
space, and or minor thyroid cartilage erosion 
T4a Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx 
(trachea, soft tissues of the neck, strap muscles, thyroid, or esophagus) 
T4b Tumor invades prevertebral space, encases the carotid or invades the mediastinum 
 
Subglottis 
T1 Tumor is limited to the subglotttis 
T2 Tumor extends to the vocal cord(s), with normal or impaired mobility 
T3 Tumor is limited to the larynx, with vocal cord fixation 
T4a Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx 
(trachea, soft tissues of the neck, strap muscles, thyroid, or esophagus) 
T4b Tumor invades prevertebral space, encases the carotid or invades the mediastinum 
 
Hypopharynx 
T1 Tumor is limited to one subsite of the hypopharynx and 2cm or less in dimension 
T2 Tumor invades more than one subsite of the hypopharynx or an adjacent site, or 
measures more than 2 cm but not more than 4 cm in greatest dimension without 
fixation of the hemilarynx 
T3 Tumor is more than 4 cm in greatest dimension or with fixation of the hemilarynx 
T4a Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophagus, or 
central compartment soft tissue 
T4b Tumor invades prevertebral fascia, encases the carotid or involves the mediastinum 
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Lymph Node Staging for Oral Cavity, Oropharynx, Hypopharynx and all Glottic Cancer 
N0 There is no regional nodes metastasis 
N1 Metastasis is in a single ipsilateral lymph node, 3cm or less in greatest dimension 
N2 Metastasis is in a single ipsilateral lymph node, more than 3 cm but not more than 6 
cm in greatest dimension, or metastasis is in multiple ipsilateral lymph nodes, none 
more than 6 cm in greatest dimension or bilateral or contralateral lymph nodes 
(although less than 6 cm) 
N2a Metastasis is in a single ipsilateral lymph node, more than 3 cm but not more than 6 
cm 
N2b Metastasis is in multiple ipsilateral lymph nodes, none more than 6 cm in greatest 
dimension 
N2c Metastasis is in bilateral or contralateral lymph nodes, none more than 6 cm 
N3 Metastasis is in a lymph node more than 6 cm in greatest dimension 
 
Stage Grouping 
Stage 0   Tis  N0  M0 
Stage I   T1  N0  M0 
Stage II   T2  N0  M0 
Stage III  T3  N0  M0 
T1  N1  M0 
T2  N1  M0 
T3  N1  M0 
Stage IVA  T4a  N0  M0 
T4a  N1  M0 
T1  N2  M0 
T2  N2  M0 
T3  N2  M0 
T4a  N2  M0 
Stage IVB  T4b  Any N  M0 
Any T  N3  M0 
Stage IVC  Any T  Any N  M1 
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Appendix 2. 
 
Yale Free Flap Monitoring Survey 
 
1. Which of the following clinical assessment techniques do you use to assess cutaneous free flap 
viability post-operatively? (Select all that apply) 
Capillary refill 
Flap Color 
Skin Turgor 
Tissue Edema 
I do not rely on clinical assessment of flap viability  
Other  
 
 Comments:  
 
2. Which of the following objective measures do you use in assessing flap viability post-
operatively?  
(Select all that apply) 
Implantable Doppler Cuff at vascular pedicle 
Intravenous Sodium Fluorescein monitoring 
Lancet (prick) and Bleeding  
Microdialysis  
Muscle contractility testing 
Non-Invasive Laser Doppler Ultrasonography 
Photoplethysmograph 
Plethysmograph 
Pulse Oximetry 
Temperature monitoring 
Transcutaneous O2 monitoring 
Tissue Oxygen Tension (microelectrodes) 
Tissue pH monitoring 
Tissue Spectrophotometry 
  Other: 
 
Comments: 
 
3. Are clinical assessment techniques or objective measures more important to you in making the 
decision to re-explore the vascular pedicle in a threatened flap? 
Clinical assessment 
Objective Tests 
  
Comments: 
 
4. Would you be open to using a different objective monitoring technique? 
Yes  
No 
 
5. Is the expense of objective monitoring techniques a consideration in your choice of instruments? 
Yes  
No 
6. Is staff training a barrier to the use of newer, free flap objective monitoring technologies? 
Yes  
No 
 
7. Any other comments about post operative monitoring of free tissue flaps:  
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DATA TABLES 
Table 1. Oxygen Microelectrode Measurements Obtained After Vein or Artery Clamping 
 
Measure  Vein (n=3) Artery (n=2) 
Oxygen tension (mmHg) 
 Before Clamp 28.53 18.85 
 5 Minutes 23.73 6.56 
 10 Minutes 17.5 7.57 
 15 Minutes 16.26 8.47 
Blood Flow (LDF) 
 Before Clamp 317 497 
 5 Minutes 288 153 
 10 Minutes 280 119 
 15 Minutes 249 148 
 
 
Table 2. Capillary Blood Gas Measurements Obtained After Vein Clamping: Mean +/- 1 
Standard Deviation 
 
Vein Clamp 
(n=8) 
Time pO2 (mmHg) pH pCO2 (mmHg) HCO3 
 Before clamp 42.71 (+/- 5.12) 7.38 (+/- 0.04) 41.13 (+/-7.68) 23.38 (+/- 3.11) 
 10 Minutes 31.57 (+/- 7.83) 7.33 (+/- 0.05) 39.00 (+/- 9.80) 21.16 (+/- 3.66) 
 20 minutes 28.67 (+/- 6.28) 7.30 (+/- 0.04) 43.50 (+/- 11.20) 21.17 (+/- 6.11) 
 
 
Table 3. Statistical analysis of changes in Capillary Blood Gas measurements from 
control at 10 and 20 minutes following venous clamping using the paired t-test. 
 
Time Interval Statistical Value pO2 (mmHg) pH pCO2 HCO3 
Time 0-10 min      
 p value *0.014 *0.024 0.539 0.227 
 DF 5 6 6 6 
 95% CI (3.74, 20.26) (0.0008, 0.080) (-5.51, 9.51) (-1.51, 5.20) 
Time 0-20 min      
 p value *<0.001 *0.032 0.65 0.523 
 DF 4 5 5 5 
 95% CI (14.72, 22.08) (0.01, 0.16) (-20.26, 13.93) (-5.59, 10.28) 
*p<0.05, DF=degrees of freedom, CI=confidence interval 
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FIGURES 
 
Figure 1 A typical recording performed with the Bare-Fibre Oxygen 
Microelectrode showing oxygen tension (pO2, mm Hg) and flow (perfusion units) 
before, during and after venous clamping 
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Figure 2 A typical recording performed with the Bare-Fibre Oxygen 
Microelectrode showing oxygen tension (pO2, mm Hg) and flow (perfusion units) 
before, during, and after arterial clamping. 
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Figure 5. 
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Figure 8. 
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Figure 11. 
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